SCHEMBL5689767

SCHEMBL5689767

O=C(O)c1ccc(-n2nnnc2SC2CCN(C(=O)Oc3ccc(CCOc4ccccn4)cc3)CC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.42
KMT2A Q03164 5/20 0.39
MEN1 O00255 3/20 0.39
PPARG P37231 1/20 0.39
ALDH1A1 P00352 7/20 0.38
MAPK1 P28482 2/20 0.38
TSHR P16473 2/20 0.37
TP53 P04637 2/20 0.37
MAPT P10636 3/20 0.37
POLB P06746 1/20 0.36
SLC6A7 Q99884 1/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
CCR6 P51684 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
ATM Q13315 1/20 0.35
GFER P55789 1/20 0.35
GRIN2B Q13224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5691510 0.89 HPGD (0.40) HPGDKMT2AMEN1PPARGALDH1A1
SCHEMBL5688293 0.88 HPGD (0.46) HPGDKMT2AMEN1PPARGALDH1A1
SCHEMBL5688291 0.87 HPGD (0.40) HPGDKMT2AMEN1PPARGALDH1A1
SCHEMBL5687655 0.87 HPGD (0.44) HPGDKMT2AMEN1PPARGALDH1A1
SCHEMBL5688835 0.85 TDP1 (0.38) KMT2AMEN1ALDH1A1MAPK1SLC6A7
SCHEMBL5931895 0.85 GRIN2B (0.39) ALDH1A1MAPK1TSHRSLC6A7GRIN2B
SCHEMBL5688982 0.84 NPSR1 (0.40) HPGDKMT2AMEN1PPARGALDH1A1
SCHEMBL5688230 0.83 HPGD (0.43) HPGDKMT2AMEN1PPARGALDH1A1
SCHEMBL5931500 0.83 FFAR1 (0.39) HPGDALDH1A1MAPK1TSHRSLC6A7
SCHEMBL5688328 0.82 NPSR1 (0.41) HPGDKMT2AMEN1PPARGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US claimed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP claimed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO claimed
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US disclosed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP disclosed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160851-A1 Substituted piperidine carbamates LIPE, PNLIP, LIPC HPGD 1372/4885KMT2A 1520/4885MEN1 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.